Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Development of Immunosuppression Regimens to Facilitate Single Donor Islet Transplantation Using Abatacept.

Trial Profile

Development of Immunosuppression Regimens to Facilitate Single Donor Islet Transplantation Using Abatacept.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Jul 2016

At a glance

  • Drugs Abatacept (Primary)
  • Indications Islet cell transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 04 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 23 May 2012 Planned end date changed from 1 Dec 2010 to 1 Dec 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top